Gene Therapy
Gene Therapy

Filter

Locations


Result types


Type of company


Industries


Company status

Number of employees

to

Founding year

to


Lock keywords

Exclude keywords

Optional keywords

Clear filters

Products and services for "Gene Therapy"

Image for HSC Gene Therapy – AVROBIO
Product

Verified

HSC Gene Therapy – AVROBIO

Our ApproachHSC Gene Therapy | Explore more | You are now leaving AVROBIO’s website.

by Avrobio

Image for Gene Therapies - ViruSure - Advanced therapies curing or modifying genes
Product

Verified

Gene Therapies - ViruSure - Advanced therapies curing or modifying genes

ViruSure has decades of experience in developing virus neutralization assays as well as in performing tumorigenicity, oncogenicity and biodistribution studies in our state-of-the-art in vivo facilities.

by ViruSure

Image for Gene Therapy | R&D Areas - iBET
Product

Verified

Gene Therapy | R&D Areas - iBET

Gene therapy is a major area of research at iBET, focusing on the development of platforms for the production and purification of virus

by iBET - Instituto de Biologia Experimental e Tecnológica

Image for What is Gene Therapy? - Moonbow
Product

Verified

What is Gene Therapy? - Moonbow

What is Gene Therapy?

by Moonbow

Image for Gene therapy
Product

Verified

Gene therapy

Gene therapy | Recombinant human albumin for optimizing virus based therapies | Enquire about Recombumin® | CONTACT | Albumedix - Dedicated to Better Health | FOLLOW US

by Albumedix

Image for iLite® Gene Therapy Solutions
Product

Verified

iLite® Gene Therapy Solutions

Svar can offer assistance in any gene therapy project. We have robust platforms suited for all phases of drug development, experience, and knowledge.

by Wieslab a Svar Life Science company

Image for Modified & Novel Vehicles for Gene Therapy Candidates
Product

Verified

Modified & Novel Vehicles for Gene Therapy Candidates

BioAgilytix has the expertise to effectively evaluate innate, cell-mediated & humoral adaptive immunity in the context of your unique gene delivery vehicle.

by Cambridge Biomedical Inc.

Image for Gene Therapy Packaging Services | Frozen Vial Labeling | Sharp
Product

Verified

Gene Therapy Packaging Services | Frozen Vial Labeling | Sharp

We manage the complex process of labeling & packaging gene therapies and other small batch, cold-chain biotech products.

by Sharp Corp

Image for Gene Therapy Methods, 346– Booksmart
Product

Verified

Gene Therapy Methods, 346– Booksmart

Gene Therapy Methods: Volume 346

by Booksmart

Image for Gene Therapy
Service

Verified

Gene Therapy

Svar Bioanalytical Services Focus Area - Gene Therapy

by Wieslab a Svar Life Science company

612 companies for "Gene Therapy"

CELL THERAPIES PTY LTD's Logo

Melbourne, Australia

11-50 Employees

2002

Cell Therapies is a contract development and manufacturing organization that manufactures and deploys advanced cell-based therapies to the global market. Established in 2003, cell therapies is one of the most experienced GMP compliant manufacturers of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products globally. Our services cover the complete manufacturing process from program development, clinical trial design and deployment, to commercial supply. Our services cover the complete manufacturing process from development to deployment, providing needle-to-needle control with clinical integration. Our facility holds both commercial supply and clinical trial manufacturing licenses from the Australian Therapeutic Goods Administration (TGA), ensuring the products from our facility meet global regulatory standards such as for U.S. (FDA), Europe (EMA), Japan and other jurisdictions.

+

Featured

Core business
Image for Groundbreaking cell and gene therapy manufacturing and commercialization

Groundbreaking cell and gene therapy manufacturing and commercialization

... Groundbreaking cell and gene therapy manufacturing and commercialization cell therapies is an Australian-based, globally-active commercial contract developm ...

Miltenyi Biomedicine's Logo

Bergisch Gladbach, Germany

51-100 Employees

2019

USA). that may not offer the same level of data protection as the laws in your country of residence. In such cases, it is possible that authorities of these third countries may access the data. Further information can be found in our Privacy Statement and Cookie Statement. Miltenyi Biomedicine Inc.1201 Clopper Road,Gaithersburg, MD 20878,USA.Get directions. Committed to bringing innovative cancer treatments and regenerative therapies to patients worldwide. Miltenyi Biomedicine is a biopharmaceutical company whose mission is to bring accessible and innovative cancer treatments and regenerative therapies to patients.We strive to make a difference for patients who fight serious diseases every day – to improve their quality of life and give them the chance to live fully and create new dreams.

+

Featured

Core business
Image for Innovation in cell and gene therapies

Innovation in cell and gene therapies

... Miltenyi Biomedicine GmbH is a newly established biopharmaceutical company that develops innovative cell and gene therapies ...

Nanocell Therapeutics's Logo

Utrecht, Netherlands

1-10 Employees

NanoCell Therapeutics, Inc. is a company developing a new biological entity-based targeted gene therapy platform, with the vision to make cell engineered therapies affordable, scalable, and accessible for the general patient population. Our cell-directed polymeric nanoparticle technology is able to deliver DNA plasmids and RNA to specific cells of interest, such as T cells, upon i.v. administration. Our new class of medicines has the potential to transform CAR-T and TCR therapies and beyond.

+

Featured

Core business
Image for Transforming cell & gene therapy

Transforming cell & gene therapy

... NanoCell Therapeutics – Transforming cell & gene therapy ...

REGENXBIO's Logo

251-500 Employees

2009

We are developing gene therapy product candidates in the retinal, metabolic and neurodegenerative therapeutic areas. Our gene therapy product candidates all utilize AAV viral vectors from our proprietary gene delivery platform, which we call our NAV® Technology Platform. In addition to our internal product candidate programs, we also selectively license our NAV Vectors to other leading biotechnology companies.

+

Featured

Core business
Image for Pioneers in Gene Therapy

Pioneers in Gene Therapy

... Pioneers in Gene Therapy ...

Nephrogen's Logo

Palo Alto, United States

1-10 Employees

2015

Our initial indication is autosomal dominant polycystic kidney disease (ADPKD), which affects 600,000 Americans and has no cure or effective treatment. Tolvaptan (JYNARQUE®) is the only FDA approved drug for ADPKD, costs $13K for a 28-day supply, and must be taken twice daily for decades for maximum benefit. Our solution aims to halt ADPKD from the onset and provide an outright cure for the disease.We're boldly committed to reimagining therapeutics for life threatening kidney disease. Our broad patent portfolio will allow us to rapidly translate our technologies into foundational partnerships and transformative treatments. Our groundbreaking platform combines the power of CRISPR-Cas genome editing with the latest advances in nucleic delivery, such as adeno-associated viruses (AAVs), to create a solution that targets kidney disease at the source.

+

Featured

Core business
Image for We're building  curative gene therapies for life threatening kidney diseases.

We're building  curative gene therapies for life threatening kidney diseases.

... Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease (ADPKD). ...

Advanced Cell & Gene Therapy's Logo

Chapel Hill, United States

11-50 Employees

+

Featured

Core business
Image for Cell and Gene Therapy:

Cell and Gene Therapy:

... Cell and Gene Therapy Consultants | ADVANCED CELL & GENE THERAPY ...

SIRION BIOTECH's Logo

Planegg, Germany

11-50 Employees

2007

SIRION Biotech’s cutting edge technologies support innovators in cell therapy, gene therapy, and vaccination using viral vectors to deliver target genes to patients, improving the clinical efficacy and safety of therapeutic products. Our strong IP portfolio supports the entire CGT value chain from discovery to commercialization and is accessible to industrial partners and academic institutions at the forefront of the gene and cell therapy (CGT) revolution. To optimize adeno-associated vectors (AAV) for gene therapy applications we offer capsid optimization, therapeutic expression cassette optimization, and manufacturing technologies. Lentivirus surface modification technology retargets lentiviral vectors to specific molecular structures while SIRIONs transduction enhancer LentiBOOST® improves clinical outcome of ex-vivo cell therapies. Technologies include our proprietary adenoviral vector Ad19a/64 plus technologies such as BAC to easily generate and manufacture recombinant adenoviral particles.

+

Featured

Product
Image for AAV Vector Technologies for Gene Therapy

AAV Vector Technologies for Gene Therapy

... AAV vectors are used in multiple gene therapy programs all over the world. About 30 percent of clinical gene therapy trials worldwide use this vector platform. ...

CGT Catapult's Logo

London, United Kingdom

101-250 Employees

2012

CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world. We are a team of experts covering all aspects of advanced therapies. Applying our unique capabilities and assets, we collaborate with academia, industry, and healthcare providers to develop new technology and drive innovation. CGT Catapult is part of a network of world-leading technology and innovation centres, established by Innovate UK. The Catapult Network foster collaborations between industry, government, research organisations, academia, and many others to transform great ideas into valuable products and services.

+

Featured

Core business
Image for Advancing cell and gene therapies through powerful collaborations - Cell and Gene Therapy

Advancing cell and gene therapies through powerful collaborations - Cell and Gene Therapy

... Advancing cell and gene therapies through powerful collaborations - Cell and Gene Therapy ...

Lentigen's Logo

Gaithersburg, United States

11-50 Employees

2005

In cell and gene therapy, from early clinical development to successful IND/CTA application, our customers around the world trust Miltenyi Bioindustry as their partner in rolling out new therapies. With our expertise, breakthrough platforms, and tailored service offerings, Miltenyi Bioindustry helps from early clinical trials to large-scale global operations. Our commitment to making new therapies a reality began with the development of the CliniMACS® Plus Instrument, the world’s first automated cell separation device, and led to the FDA approval of the CliniMACS® CD34 Reagent System. The launch of the fully automated CliniMACS Prodigy® Platform set the standard for automated, scalable, and GMP-compliant cell processing and manufacturing. The latest addition of the associated CliniMACS® Electroporator and CliniMACS® Formulation Unit modules pushes this standard still further and opens up entirely new possibilities for true and fully integrated end-to-end solutions in cell and gene therapy manufacturing.

+

Featured

Service
Image for Our cell and gene therapy services

Our cell and gene therapy services

... We provide process development and manufacturing services for your cell and gene therapy products. Learn more about our CDMO service offering. ...

Limula's Logo

La Tour-de-Peilz, Switzerland

1-10 Employees

2020

+

Featured

Core business
Image for Cell and Gene Therapy Made Easy

Cell and Gene Therapy Made Easy

... Limula – Cell and Gene Therapy Made ...

Show More

„Gene Therapy“

Gene therapy is a type of medical treatment that involves introducing genetic material into the body to modify or replace a faulty gene. It is used to treat a variety of genetic diseases and disorders, including cancer and inherited conditions such as muscular dystrophy and cystic fibrosis. Gene therapy works by introducing healthy copies of a gene or gene-modifying agents into the cells of a patient in order to correct or replace a mutated or missing gene. In many cases, gene therapy is used to supplement traditional treatments, such as medications or surgery.